FDA Adverse Event Injury Summary report: N

HARMONIC SCALPEL CURVED SHEAR (EXACT CODE UNKNOWN)

MDR report key: 9511141 · Received December 23, 2019

Report

Report Number
3005075853-2019-24736
Event Type
Injury
Date Received
December 23, 2019
Report Date
December 2, 2019
Manufacturer
ETHICON ENDO-SURGERY, LLC.
Product Code
GEI
PMA / PMN Number
GEI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DATE SENT: 12/23/2019. BATCH # UNK. DATE OF EVENT: PUBLICATION YEAR FOR THE JOURNAL ARTICLE IS 2011. THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE MANUFACTURING RECORDS CANNOT BE REVIEWED AS THE LOT/BATCH NUMBER HAS NOT BEEN PROVIDED.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A REVIEW OF A JOURNAL ARTICLE, TITLE: THE OUTCOME OF LAPAROSCOPIC RADICAL HYSTERECTOMY (LRH) AND PELVIC LYMPHADENECTOMY IN PATIENTS WITH EARLY INVASIVE CERVICAL CANCER. AUTHOR/S: JIHAD D.; FRITZ J. CITATION: GYNECOL SURG (2011) 8 (SUPPL 1):S185. DOI 10.1007/S10397-011-0694-4. THE AIM OF THIS STUDY WAS TO EVALUATE RETROSPECTIVELY FEASIBILITY AND ONCOLOGICAL OUTCOME OF LAPAROSCOPIC RADICAL HYSTERECTOMY (LRH) IN PATIENTS WITH IB1 STAGE CERVICAL CANCER. THIS RETROSPECTIVE STUDY INVOLVES 50 PATIENTS WITH CERVICAL CANCER (STAGE IB1) AND WERE TREATED WITH LRH AND PELVIC LYMPHADENECTOMY. THE RADICAL HYSTERECTOMY WAS PERFORMED USING THE HARMONIC SCALPEL (ETHICON). REPORTED COMPLICATION INCLUDED POSTOPERATIVE BLEEDING (N-1) WHICH NEEDED A SECOND SURGERY, AND URETEROVAGINAL FISTULA AFTER THE OPERATION (N-1). IN CONCLUSION, THE LRH IS FEASIBLE WITH EXCELLENT SURGICAL AND ONCOLOGICAL OUTCOME WHICH IS COMPARABLE TO PATIENTS TREATED WITH LAPAROTOMY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1304416 HARMONIC SCALPEL CURVED SHEAR (EXACT CODE UNKNOWN) ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES GEI ETHICON ENDO-SURGERY, LLC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention